2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
Sanandaji N et al. Comparison of oligonucleotide migration in a bicontinuous cubic phase of monoolein and water and in a fibrous agarose hydrogel. 2006 Electrophoresis pmid:16807936
Zawalich WS and Zawalich KC Forskolin-induced desensitization of pancreatic beta-cell insulin secretory responsiveness: possible involvement of impaired information flow in the inositol-lipid cycle. 1990 Endocrinology pmid:1691696
Zawalich WS et al. Interleukin-1 alpha exerts glucose-dependent stimulatory and inhibitory effects on islet cell phosphoinositide hydrolysis and insulin secretion. 1989 Endocrinology pmid:2539976
Zawalich WS Phosphoinositide hydrolysis and insulin secretion in response to glucose stimulation are impaired in isolated rat islets by prolonged exposure to the sulfonylurea tolbutamide. 1989 Endocrinology pmid:2544404
Zhu Q et al. A two-stage enzymatic process for synthesis of extremely pure high oleic glycerol monooleate. 2011 Enzyme Microb. Technol. pmid:22112823
Shah MH and Paradkar A Effect of HLB of additives on the properties and drug release from the glyceryl monooleate matrices. 2007 Eur J Pharm Biopharm pmid:17353118
Lopes LB et al. Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer. 2005 Eur J Pharm Biopharm pmid:15848052
Steluti R et al. Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin. 2005 Eur J Pharm Biopharm pmid:15996585
Wörle G et al. Effect of drug loading on the transformation of vesicular into cubic nanoparticles during heat treatment of aqueous monoolein/poloxamer dispersions. 2006 Eur J Pharm Biopharm pmid:16497495
Lopes LB et al. Liquid crystalline phases of monoolein and water for topical delivery of cyclosporin A: characterization and study of in vitro and in vivo delivery. 2006 Eur J Pharm Biopharm pmid:16621488
Ahmed AR et al. Reduction in burst release of PLGA microparticles by incorporation into cubic phase-forming systems. 2008 Eur J Pharm Biopharm pmid:18692569
Onoue S et al. Inhalable dry-emulsion formulation of cyclosporine A with improved anti-inflammatory effects in experimental asthma/COPD-model rats. 2012 Eur J Pharm Biopharm pmid:22008148
Vicentini FT et al. Liquid crystalline phase nanodispersions enable skin delivery of siRNA. 2013 Eur J Pharm Biopharm pmid:23010565
Morsi NM et al. Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. 2014 Eur J Pharm Biopharm pmid:23688805
Sallam AS et al. Formulation of an oral dosage form utilizing the properties of cubic liquid crystalline phases of glyceryl monooleate. 2002 Eur J Pharm Biopharm pmid:11976023
Carneiro C et al. DODAB:monoolein liposomes containing Candida albicans cell wall surface proteins: a novel adjuvant and delivery system. 2015 Eur J Pharm Biopharm pmid:25499956
Tiossi RF et al. In vitro and in vivo evaluation of the delivery of topical formulations containing glycoalkaloids of Solanum lycocarpum fruits. 2014 Eur J Pharm Biopharm pmid:24509413
Rizwan SB et al. Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines. 2011 Eur J Pharm Biopharm pmid:21237267
Donida B et al. Monoolein-based nanoparticles for drug delivery to the central nervous system: A platform for lysosomal storage disorder treatment. 2018 Eur J Pharm Biopharm pmid:30315863
Simonetti LD et al. Assessment of the percutaneous penetration of cisplatin: the effect of monoolein and the drug skin penetration pathway. 2009 Eur J Pharm Biopharm pmid:19442727